Yukihiro Yoshikawa Selected Research

Yukihiro Yoshikawa Research Topics

Disease

13	Neoplasms (Cancer) 05/2024 - 11/2013
6	Neoplasm Metastasis (Metastasis) 05/2024 - 11/2013
6	Stomach Neoplasms (Stomach Cancer) 04/2024 - 11/2013
4	Lymphatic Metastasis 04/2024 - 11/2012
4	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 05/2022
4	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 11/2014
3	Colonic Neoplasms (Colon Cancer) 02/2024 - 03/2021
3	Sigmoid Neoplasms 12/2022 - 11/2012
2	Rectal Neoplasms (Rectal Cancer) 05/2024 - 04/2022
2	Disease Progression 01/2023 - 02/2020
2	Pathologic Constriction (Stenosis) 12/2022 - 11/2015
2	Pyloric Stenosis 12/2021 - 11/2013
1	Anus Neoplasms (Anal Cancer) 05/2024
1	Hemorrhage 02/2024
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2024
1	Multiple Myeloma 02/2024
1	Intussusception 04/2023
1	Kidney Neoplasms (Kidney Cancer) 12/2022
1	Pancreatic Ductal Carcinoma 12/2022
1	Abdominal Pain (Pain, Abdominal) 12/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022
1	Abdominal Aortic Aneurysm 12/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2022
1	Anemia 12/2022
1	Colic (Abdominal Cramps) 06/2022
1	Anastomotic Leak 04/2022
1	Neoplasms, Cystic, Mucinous, and Serous 12/2020
1	Adenosquamous Carcinoma 12/2020
1	Inguinal Hernia (Direct Inguinal Hernia) 07/2020
1	Esophageal Squamous Cell Carcinoma 05/2020
1	Carcinogenesis 05/2020
1	Genomic Instability 01/2020
1	Breast Neoplasms (Breast Cancer) 08/2018
1	Intestinal Fistula 11/2015
1	Esophageal Neoplasms (Esophageal Cancer) 11/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2012
1	Neutropenia 11/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2018
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2023 - 11/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2023 - 12/2021
2	NivolumabIBA 03/2023 - 12/2021
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 12/2022
2	Gemcitabine FDA Link 12/2022 - 12/2020
1	Panitumumab (Vectibix)FDA Link 05/2024
1	Thalidomide (Thalomid)FDA Link 02/2024
1	Lenalidomide (CC 5013)FDA Link 02/2024
1	RamucirumabIBA 03/2023
1	CarbohydratesIBA 01/2023
1	AntigensIBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2022
1	RNA Splicing FactorsIBA 05/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2020
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 11/2013
1	Trastuzumab (Herceptin)FDA Link 11/2013
1	human ERBB2 proteinIBA 11/2013
1	ErbB Receptors (EGF Receptor)IBA 11/2013

Therapy/Procedure

6	Colectomy 02/2024 - 07/2020
5	Drug Therapy (Chemotherapy) 05/2024 - 11/2012
4	Lymph Node Excision (Lymph Node Dissection) 05/2024 - 11/2013
4	Therapeutics 05/2022 - 11/2013
4	Gastrectomy 12/2021 - 11/2013
2	Hepatectomy 12/2022 - 11/2014
2	Pancreatectomy 12/2022 - 11/2013
2	Radiotherapy 12/2021 - 02/2020
2	Pancreaticoduodenectomy 12/2020 - 11/2013
1	Proctectomy 05/2024
1	Ovariectomy (Oophorectomy) 08/2023
1	Colostomy 12/2022
1	Endovascular Aneurysm Repair 12/2022
1	Minimally Invasive Surgical Procedures 10/2022
1	Ligation 10/2022
1	Robotic Surgical Procedures 04/2022
1	Laparotomy 04/2022
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2021
1	Radiofrequency Ablation 02/2021
1	Operative Surgical Procedures 12/2020
1	Chemoradiotherapy 12/2020
1	Self Expandable Metallic Stents 11/2015
1	Esophagectomy 11/2015
1	Home Parenteral Nutrition 11/2015
1	Nephrectomy 11/2013
1	Intravenous Infusions 11/2013
1	Combination Drug Therapy (Combination Chemotherapy) 11/2013